Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




ADHD Drug Complements Body's Dopamine System

By HospiMedica staff writers
Posted on 12 Jul 2006
The brain's dopamine system, which has long been linked with reward learning and reward-related behavior, works differently in treated and untreated attention deficit hyperactivity disorder (ADHD) individuals, according to a new study.

"The significant difference we found between treated and untreated ADHD patients provides an important hint on the effect of the most commonly prescribed drug for this disease, which has long baffled and frustrated parents and physicians,” noted co-author of the study, Dr. More...
Felix M Mottaghy, a research fellow at the University of Ulm (Germany). Until this study, there has been no direct evidence pointing to the beneficial effect of methylphenidate (drugs such as Ritalin) on the body's dopamine system, added Dr. Mottaghy. The study was presented by the German researchers at the Society of Nuclear Medicine's (SNM) 53rd annual meeting, held in June 2006 in San Diego (CA, USA).

For years, researchers have hypothesized that methylphenidate relaxes people with ADHD by increasing the release of the neurotransmitter dopamine, improving attention and focus in those who have weak dopamine signals.

The primary features of ADHD are inattention, hyperactivity, and impulsivity, and this disorder can manifest early in a child's life, sometimes as early as preschool. With ADHD, there is an imbalance of several neurotransmitter systems, according to Dr. Mottaghy. "The most affected seemed to be the dopaminergic system. Until now most studies focused on the so-called postsynaptic or receiving part of this system,” he explained. "Our study shows that the beneficial effect of methylphenidate is received via ‘normalization' of the dopamine system. We demonstrated that the brain's dopamine system--including midbrain, the striatum, and the amygdal--is differentially modulated in treated and untreated ADHD patients with respect to healthy normal controls. Methylphenidate leads to a harmonization of the presynaptic dopaminergic neurons that could explain in part the beneficial effects of this central nervous system stimulant.”

The investigators utilized positron emission tomography (PET), a noninvasive brain scanning method, with 18F-DOPA, an imaging agent that is a precursor of dopamine. The researchers also used statistic parametric mapping to obtain the statistical comparison of normalized and reoriented brain images, according to Dr. Mottaghy.



Related Links:
University of Ulm

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.